Condition: Cardiovascular Kidney Metabolic Syndrome · Type 2 Diabetes · Sponsor: Ohio State University
Food and Fitness with Medicine (FFWM) is a 24-week randomized controlled trial (RCT) enrolling 200 post-menopausal women (PMW) with stage 2 cardio-kidney metabolic (CKM) syndrome and type-2 diabetes (T2D) within 6 weeks of initiating glucagon-like peptide-1 receptor agonist (GLP-1RAs) to: 1. Examine discontinuation rates of GLP-1RAs (primary outcome); 2. Compare change in American Heart Association (AHA) PREVENT scores (secondary outcome); and 3. Examine the effects of FFWM on biologic mechanisms responsive to weight loss and cardiovascular health (CVH) including dermal carotenoids, body composition and metabolite biomarkers.
This description comes directly from the study's public registry record.
Jenna N Hauben, BS · 9083344689 · jenna.hauben@osumc.edu
Cara L Chase, BS · 5032789721 · cara.chase@osumc.edu
Always discuss trial participation with your own doctor first.
| Ohio State Healthy Community Center | Columbus, Ohio, United States | Active Not Recruiting |
| Ohio State East Hospital | Columbus, Ohio, United States | Not Yet Recruiting |
| Martha Morehouse | Columbus, Ohio, United States | Recruiting |
| Ohio State Outpatient Care Upper Arlington | Upper Arlington, Ohio, United States | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07027995